Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems. The Zacks Consensus Estimate for its current year earnings has been revised 2.2% downward over the last 30 days.
BancorpSouth, Inc. provides commercial banking and financial services to individuals and small-to-medium size businesses. The Zacks Consensus Estimate for its current year earnings has declined almost 2% over the last 30 days.
Boise Cascade Company (BCC - Free Report) manufactures wood products and distributes building materials. It has seen the Zacks Consensus Estimate for its current year earnings being revised 14.3% downward over the last 30 days.
Cimpress NV (CMPR - Free Report) is a technology driven company, which aggregates small and individually customized orders print, signage, apparel, and other products. The Zacks Consensus Estimate revision for its current year earnings was a negative of 8.8% over the last 30 days.
Costamare Inc. (CMRE - Free Report) owns and charters containerships to liner companies worldwide. The Zacks Consensus Estimate for its current year earnings has moved 8.6% lower over the last 30 days.
View the entire Zacks Rank #5 List
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems. The Zacks Consensus Estimate for its current year earnings has been revised 2.2% downward over the last 30 days.
BancorpSouth, Inc. provides commercial banking and financial services to individuals and small-to-medium size businesses. The Zacks Consensus Estimate for its current year earnings has declined almost 2% over the last 30 days.
Boise Cascade Company (BCC - Free Report) manufactures wood products and distributes building materials. It has seen the Zacks Consensus Estimate for its current year earnings being revised 14.3% downward over the last 30 days.
Cimpress NV (CMPR - Free Report) is a technology driven company, which aggregates small and individually customized orders print, signage, apparel, and other products. The Zacks Consensus Estimate revision for its current year earnings was a negative of 8.8% over the last 30 days.
Costamare Inc. (CMRE - Free Report) owns and charters containerships to liner companies worldwide. The Zacks Consensus Estimate for its current year earnings has moved 8.6% lower over the last 30 days.
View the entire Zacks Rank #5 List
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on BCC - FREE
Get the latest research report on CMRE - FREE
Get the latest research report on CMPR - FREE